BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32390613)

  • 21. Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS.
    Reed C; Belger M; Scott Andrews J; Tockhorn-Heidenreich A; Jones RW; Wimo A; Dodel R; Haro JM
    Int Psychogeriatr; 2020 Feb; 32(2):267-277. PubMed ID: 31134870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The financial burden and health care utilization patterns associated with amnestic mild cognitive impairment.
    Ton TGN; DeLeire T; May SG; Hou N; Tebeka MG; Chen E; Chodosh J
    Alzheimers Dement; 2017 Mar; 13(3):217-224. PubMed ID: 27693186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-professional caregiver burden is associated with the severity of patients' cognitive impairment.
    Black CM; Ritchie CW; Khandker RK; Wood R; Jones E; Hu X; Ambegaonkar BM
    PLoS One; 2018; 13(12):e0204110. PubMed ID: 30521532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Dementia-Related Behavioral Symptoms on Healthcare Resource Use and Caregiver Burden: Real-World Data from Europe and the United States.
    Chekani F; Pike J; Jones E; Husbands J; Khandker RK
    J Alzheimers Dis; 2021; 81(4):1567-1578. PubMed ID: 34057080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
    Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
    J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Difference in determinants of caregiver burden between amnestic mild cognitive impairment and mild Alzheimer's disease.
    Ikeda C; Terada S; Oshima E; Hayashi S; Okahisa Y; Takaki M; Inagaki M; Yokota O; Uchitomi Y
    Psychiatry Res; 2015 Mar; 226(1):242-6. PubMed ID: 25631688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study.
    Lee DH; Isobe H; Wirtz H; Aleixo SB; Parente P; de Marinis F; Huang M; Arunachalam A; Kothari S; Cao X; Donnini N; Woodgate AM; de Castro J
    BMC Health Serv Res; 2018 Mar; 18(1):147. PubMed ID: 29490654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in direct social care costs of Alzheimer's disease in Japan depending on dementia severity.
    Takechi H; Kokuryu A; Kuzuya A; Matsunaga S
    Geriatr Gerontol Int; 2019 Oct; 19(10):1023-1029. PubMed ID: 31478311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological and economic burden of Alzheimer's disease: a systematic literature review of data across Europe and the United States of America.
    Takizawa C; Thompson PL; van Walsem A; Faure C; Maier WC
    J Alzheimers Dis; 2015; 43(4):1271-84. PubMed ID: 25159675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Real-World Evidence Analysis of Associations Among Costs, Quality of Life, and Disease-Severity Indicators of Alzheimer's Disease in Thailand.
    Kongpakwattana K; Dejthevaporn C; Krairit O; Dilokthornsakul P; Mohan D; Chaiyakunapruk N
    Value Health; 2019 Oct; 22(10):1137-1145. PubMed ID: 31563256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-world assessment of "OFF" episode-related healthcare resource utilization among patients with Parkinson's disease in the United States.
    Thach A; Jones E; Pappert E; Pike J; Wright J; Gillespie A
    J Med Econ; 2021; 24(1):540-549. PubMed ID: 33819121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results From the Real-World, Retrospective EMN23 Study.
    Jaccard A; Bridoux F; Roeloffzen W; Minnema MC; Bergantim R; Hájek R; João C; Cibeira MT; Palladini G; Schönland S; Merlini G; Milani P; Dimopoulos MA; Ravichandran S; Hegenbart U; Agis H; Gros B; Asra A; Magarotto V; Cheliotis G; Psarros G; Sonneveld P; Wechalekar A; Kastritis E
    Clin Lymphoma Myeloma Leuk; 2024 May; 24(5):e205-e216. PubMed ID: 38453615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caregiver rating bias in mild cognitive impairment and mild Alzheimer's disease: impact of caregiver burden and depression on dyadic rating discrepancy across domains.
    Pfeifer L; Drobetz R; Fankhauser S; Mortby ME; Maercker A; Forstmeier S
    Int Psychogeriatr; 2013 Aug; 25(8):1345-55. PubMed ID: 23651733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of osteoarthritis disease severity on treatment patterns and healthcare resource use: analysis of real-world data.
    Conaghan PG; Abraham L; Viktrup L; Cappelleri JC; Beck C; Bushmakin AG; Berry M; Jackson J
    Scand J Rheumatol; 2023 Jul; 52(4):353-363. PubMed ID: 35587006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.
    Reed C; Happich M; Argimon JM; Haro JM; Wimo A; Bruno G; Dodel R; Jones RW; Vellas B; Belger M
    J Alzheimers Dis; 2017; 57(3):797-812. PubMed ID: 28304285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.
    Van der Mussele S; Bekelaar K; Le Bastard N; Vermeiren Y; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):947-58. PubMed ID: 23255479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Financial Management Skills in Aging, MCI and Dementia: Cross Sectional Relationship to 18F-Florbetapir PET Cortical β-amyloid Deposition.
    Tolbert S; Liu Y; Hellegers C; Petrella JR; Weiner MW; Wong TZ; Murali Doraiswamy P
    J Prev Alzheimers Dis; 2019; 6(4):274-282. PubMed ID: 31686100
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.